There is no single testosterone level that determines whether a man should start TRT. The American Urological Association uses a total testosterone level below 300 ng/dL as a reasonable threshold for low testosterone, while reference ranges and diagnostic criteria can vary somewhat between laboratories and medical organizations.
Treatment decisions consider more than total testosterone alone. Symptoms, repeat morning testosterone measurements, and - in appropriate cases - free testosterone are considered alongside age, overall health, fertility concerns, and the potential risks, benefits, and alternatives to treatment.
The goal is to determine whether a patient has clinically meaningful testosterone deficiency and whether testosterone therapy is an appropriate treatment - not simply to treat a laboratory number.
Low testosterone can affect sexual function, energy, mood, strength, muscle mass, body composition, and overall sense of well-being. Some men notice reduced libido or fewer spontaneous erections, while others experience fatigue, decreased motivation, difficulty maintaining muscle, or changes in mood and concentration.
These symptoms are not specific to low testosterone and can have many causes. Determining whether testosterone replacement therapy (TRT) is appropriate requires looking at symptoms alongside total and free testosterone levels and the broader clinical context, including age, overall health, medications, and fertility goals. Treatment decisions should be based on the full clinical picture rather than a single testosterone level.
Some symptoms, particularly libido and energy, may begin to improve within weeks, while changes in body composition, muscle mass, and bone density generally take longer.
Current evidence does not support the older assumption that appropriately prescribed TRT causes prostate cancer, but prostate health should still be assessed and monitored based on age and individual risk. If a patient has active prostate cancer, TRT is contraindicated.
Yes, particularly when low testosterone is contributing to erectile dysfunction. Testosterone plays an important role in sexual desire, arousal, nitric oxide signaling, and the vascular and erectile tissue function necessary for healthy erections. When testosterone is low, restoring it to an appropriate range may improve libido, erectile function, and response to other ED treatments.
Testosterone therapy is not a cure for every cause of erectile dysfunction. ED is often multifactorial, and vascular disease, medications, metabolic health, or other factors may also play a role. But maintaining adequate testosterone is an important foundation for healthy sexual and erectile function.
Improved sexual desire is one of the better-established benefits of TRT in men with documented testosterone deficiency.
Yes. For younger men or men concerned about their fertility who have low testosterone levels or symptoms, there are alternatives to testosterone replacement therapy (TRT). Rather than giving exogenous testosterone - which suppresses sperm production - certain medications can stimulate the body's own testosterone production while helping preserve the hormonal signals necessary for sperm production.
Clomiphene (Clomid), and in some cases enclomiphene, may be used to stimulate the pituitary hormones LH and FSH, which support natural testosterone and sperm production. Other options, including hCG, may also be appropriate depending on a man's hormone levels, symptoms, and fertility goals.
These treatments are not appropriate for every type of testosterone deficiency. We evaluate testosterone levels, LH and FSH, symptoms, age, and current or future fertility goals to determine whether TRT or a fertility-preserving approach makes the most sense.
TRT can increase lean body mass in men with testosterone deficiency, particularly when combined with appropriate resistance training, nutrition, and metabolic health strategies.
Current high-quality evidence is reassuring regarding the cardiovascular safety of testosterone therapy when it is appropriately prescribed and monitored. The large, randomized TRAVERSE trial followed more than 5,000 men with low testosterone who had cardiovascular disease or were at increased cardiovascular risk. Rates of major cardiovascular events - including heart attack, stroke, and cardiovascular death - were similar in men receiving testosterone and those receiving placebo. In 2025, following its review of this evidence, the FDA removed the cardiovascular-risk language from the boxed warning on testosterone products.
Longer-term observational studies have also found no increase in cardiovascular events among appropriately treated men, with some studies reporting an association between testosterone therapy and lower rates of cardiovascular events and mortality. These studies cannot establish that testosterone itself is protective, but the overall evidence is increasingly reassuring.
Cardiovascular health remains an important part of testosterone treatment. We evaluate cardiovascular risk before treatment and monitor factors such as blood pressure, blood counts, metabolic health, and other cardiovascular risk markers throughout therapy.
Yes. Exogenous testosterone can significantly suppress sperm production and, in some men, reduce sperm counts to very low levels or even zero. This occurs because testosterone therapy suppresses the hormonal signals from the brain that stimulate the testes to produce sperm.
Sperm production can recover after testosterone is discontinued, but recovery may take months or longer and is not guaranteed. In some men, sperm production may not fully return to baseline.
For this reason, younger men and anyone considering future children should likely avoid TRT or seek alternatives with an informed provider. Men with symptoms of low testosterone who want to preserve fertility may have alternative treatment options that can support testosterone production while maintaining sperm production.
Not necessarily. However, many causes of testosterone deficiency are persistent, so some men choose to remain on TRT long term because symptoms and low testosterone levels return when treatment is stopped.
TRT suppresses the body's natural testosterone production. After discontinuing treatment, levels can recover, but the timing and degree of recovery vary based on age, duration of treatment, baseline hormone function, and the underlying cause of low testosterone.
Lifestyle changes - including improvements in weight, metabolic health, sleep, and exercise - may improve natural testosterone production in some men. TRT should therefore be viewed as an individualized treatment decision rather than an automatic lifelong commitment.
Monitoring commonly includes free and total testosterone levels, CBC/hematocrit, PSA (prostate), and metabolic panel, along with additional testing based on the patient's individual health and treatment plan.
There is no single best delivery method for every patient. Injections, topical therapy, pellets, oral, and other formulations each have advantages and tradeoffs that should be matched to the individual.
Schedule a consultation with the Performance Men's Health team.